Global Lichen Nitidus Treatment Market Size, Status and Forecast 2021-2027

Lichen nitidus is a chronic inflammatory disease of unknown cause characterized by 1–2 mm, discrete and uniform, shiny, flat-topped, pale flesh-colored or reddish-brown papules that may appear as hypopigmented against dark skin. Occasionally, minimal scaling is present or can be induced by rubbing the surface of the papules. The disease usually affects children and young adults and is painless and usually nonpruritic, although protracted itching may occur in some cases. It is sometimes referred to by dermatologists as "mini lichen planus".
Generally, lichen nitidus is asymptomatic and self-limited.Therefore, no treatment is required. However, if persistent pruritus is present, topical glucocorticoids may be tried. If the disease process is symptomatic, generalized and extensive, oral glucocorticoids may be indicated. Other reported treatments include PUVA, UVA/UVB phototherapy, astemizole, acitretin, and etretinate.

Market Analysis and Insights: Global Lichen Nitidus Treatment Market
The global Lichen Nitidus Treatment market size is projected to reach US$ 149.9 million by 2027, from US$ 103.9 million in 2020, at a CAGR of 4.9% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lichen Nitidus Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lichen Nitidus Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lichen Nitidus Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lichen Nitidus Treatment market.

Global Lichen Nitidus Treatment Scope and Market Size
Lichen Nitidus Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lichen Nitidus Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Topical
Oral

Segment by Application
Hospitals
Dermatology Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Novartis
Merck Sharp & Dohme
Sanofi
GlaxoSmithKline
AstraZeneca
Hubei Gedian Humanwell Pharmaceutical